Barclays’s Genomic Health, Inc. GHDX Stock Holding History

Barclays’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-300	Closed	-$19K	–	7540
2018 Q4	$19K	Buy	+300	New	+$21K	﹤0.01%	5938
2018 Q2	–	Sell	-11,000	Closed	-$344K	–	7493
2018 Q1	$344K	Buy	+11,000	New	+$365K	﹤0.01%	4344
2017 Q3	–	Sell	-5,700	Closed	-$186K	–	7181
2017 Q2	$186K	Buy	+5,700	New	+$181K	﹤0.01%	4432

Barclays's GHDX Position: Q4 2019 in Review

Barclays sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 90,862 shares — an estimated $6.16M sold.

Barclays first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $6.16M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Barclays reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Barclays sold 90,862 Genomic Health, Inc. shares in Q4 2019, an estimated $6.16M.
Barclays first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
Barclays's Genomic Health, Inc. position peaked at $6.16M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.